Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA Should Have Separate Consumer Website, Panelists Say At Risk Hearing

Executive Summary

FDA should launch a separate consumer website that serves as a one-stop shop for reliable and up-to-date drug risk and adverse event information, panelists suggested at a Dec. 7-8 FDA public hearing on the communication of drug safety information

You may also be interested in...

FDA Should Reassess Patient Information Sheet Proposal, NCPIE Says

FDA should rethink its proposal for agency-issued patient information sheets, National Council on Patient Information & Education Exec VP Ray Bullman said at a recent hearing on drug safety communications

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts